US$ 22.06
bpc-157 intranasal bioavailability as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers BPC-157 + TB-500 Nasal Spray
Description
J.PaulG.ElmerE

Angiology, 35(2), 7983
A dose effect of mutations in the GBA gene on Parkinsons disease phenotype
Medications administered independently as supportive management of chemotherapy are reported separately using 96360, 96361, 96365, or 96379, as appropriate
